Reclassification of cardiovascular risk in patients with normal myocardial perfusion imaging using heart rate response to vasodilator stress.
about
Safety and tolerability of regadenoson CMR.Regadenoson: a focused update.Regadenoson use in chronic kidney disease and end-stage renal disease: A focused review.The prognostic value of non-perfusion variables obtained during vasodilator stress myocardial perfusion imaging.The reproducibility and prognostic value of serial measurements of heart rate response to regadenoson during myocardial perfusion imaging.Review of cardiovascular imaging in the journal of nuclear cardiology in 2016: Part 2 of 2-myocardial perfusion imaging.Prognostic value of heart rate response during regadenoson stress myocardial perfusion imaging in patients with end stage renal disease.Effect of changes in perfusion defect size during serial regadenoson myocardial perfusion imaging on cardiovascular outcomes in high-risk patients.The heart rate response to regadenoson in patients with atrial fibrillation.The prognostic value of heart rate response during vasodilator stress myocardial perfusion imaging in patients with end-stage renal disease undergoing renal transplantation.
P2860
Q33767994-32EE72DE-64D0-4859-A9CE-9EE18EBB9DBCQ38066403-F46025CD-4DE9-4358-8295-329DD71A7A62Q38707736-8C031C68-422D-4062-A15B-E4BD6C4C2D15Q38759839-8FD818DD-887E-49CB-91CE-A71E6091CCC6Q38808550-47766D60-7E43-4DE2-AF7C-4AD91366D624Q39225868-661009D6-A4BD-43FB-B0BB-A7459649C0E7Q40622248-5D8E425B-3DF2-4208-9096-C2948152B499Q40896705-2312495E-2DCF-46BB-A102-2B357C131E3AQ47782755-80B4576E-D123-4E70-B22D-EE1C7A1D92B3Q50027871-3AC10AFB-DFE1-4DEA-8DD0-EF1F062312D5
P2860
Reclassification of cardiovascular risk in patients with normal myocardial perfusion imaging using heart rate response to vasodilator stress.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Reclassification of cardiovasc ...... esponse to vasodilator stress.
@en
Reclassification of cardiovasc ...... esponse to vasodilator stress.
@nl
type
label
Reclassification of cardiovasc ...... esponse to vasodilator stress.
@en
Reclassification of cardiovasc ...... esponse to vasodilator stress.
@nl
prefLabel
Reclassification of cardiovasc ...... esponse to vasodilator stress.
@en
Reclassification of cardiovasc ...... esponse to vasodilator stress.
@nl
P2093
P1476
Reclassification of cardiovasc ...... esponse to vasodilator stress.
@en
P2093
Aaron Sweeney
Ami E Iskandrian
Fahad M Iqbal
Jaekyeong Heo
Kumar Sanam
Wael Al Jaroudi
P304
P356
10.1016/J.AMJCARD.2012.09.013
P407
P50
P577
2012-10-27T00:00:00Z